SCHEMBL24126484

SCHEMBL24126484

CC1(C)OB(c2cccc3c2[nH]c2c3ccc3c4ccccc4oc32)OC1(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ PGR P06401 1/20 0.39
▸ LPL P06858 1/20 0.34
▸ LIPG Q9Y5X9 1/20 0.34
▸ ERCC5 P28715 1/20 0.34
▸ FEN1 P39748 1/20 0.34
▸ ALDH1A1 P00352 6/20 0.33
▸ KDM4E B2RXH2 4/20 0.33
▸ LMNA P02545 4/20 0.33
▸ GLA P06280 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ RXFP1 Q9HBX9 6/20 0.33
▸ PPARG P37231 5/20 0.33
▸ NR2E3 Q9Y5X4 5/20 0.33
▸ NCOR2 Q9Y618 5/20 0.33
▸ HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19045125 0.85 JAK2 (0.39) KMT2AMEN1CYP2C19PGRALDH1A1
SCHEMBL31130282 0.84 MEN1 (0.44) KMT2AMEN1CYP2C19PGRLPL
SCHEMBL22698059 0.84 MEN1 (0.44) KMT2AMEN1CYP2C19PGRLPL
SCHEMBL5019780 0.83 MEN1 (0.46) KMT2AMEN1CYP2C19PGRLPL
SCHEMBL26863064 0.82 MEN1 (0.43) KMT2AMEN1CYP2C19PGRLPL
SCHEMBL21339756 0.82 MEN1 (0.43) KMT2AMEN1CYP2C19PGRLPL
SCHEMBL26599731 0.80 ERCC5 (0.38) KMT2AMEN1CYP2C19PGRERCC5
SCHEMBL26451923 0.80 KIF11 (0.41) KMT2AMEN1PGRLPLLIPG
SCHEMBL14476679 0.79 ALOX5 (0.47) KMT2AMEN1CYP2C19PGRLPL
SCHEMBL29639954 0.79 KIF11 (0.45) KMT2AMEN1LPLLIPGALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230137925-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD (JP) 2023-05-04 — — US disclosed
US-20230137925-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD (JP) 2023-05-04 — — US disclosed
WO-2021255698-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2021-12-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230137925-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND DDT, DDC, ODC1 KMT2A 1094/4885MEN1 965/4885CYP2C19 276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback